PDP1 and head and neck cancer: Cerniglia et al. reported that the genetic knockdown of AKT1 reduced the oxygen consumption rate in human head and neck cancer cell lines in vitro by 30% to 40% and increased the phosphorylation level of the PDH complex at Ser293, which again suppresses PDH activity [33].